| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/13/2009 | CA2521846C Reverse-turn mimetics and method relating thereto |
| 10/13/2009 | CA2368274C C10 ester substituted taxanes as antitumor agents |
| 10/13/2009 | CA2356331C Methods for glucagon suppression |
| 10/08/2009 | WO2005009350A3 Fugetactic proteins, compositions and methods of use |
| 10/08/2009 | US20090253777 Methods of diagnosing and treating hyperproliferative disorders |
| 10/08/2009 | US20090253714 Methods of reducing risk of infection from pathogens |
| 10/08/2009 | US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 10/08/2009 | US20090252731 Multivalent Carriers of Bi-Specific Antibodies |
| 10/08/2009 | US20090252649 Apparatus for body fluid analysis using surface-textured optical materials |
| 10/07/2009 | EP2106797A2 Controlled release oxycodone compositions |
| 10/07/2009 | EP2106796A2 Controlled release oxycodone compositions |
| 10/07/2009 | EP0983041B1 Aqueous carrier systems for water-insoluble materials |
| 10/07/2009 | CN101550190A An anti-il-12 antibody, a composition, a method and the function |
| 10/06/2009 | US7598396 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; improves performance characteristics of pharmaceutical product |
| 10/06/2009 | US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 10/06/2009 | US7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs |
| 10/06/2009 | US7598271 Crystalline paroxetine methane sulfonate |
| 10/06/2009 | US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents |
| 10/06/2009 | US7598042 Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use |
| 10/06/2009 | US7597932 Mesoporous permeation layers for use on active electronic matrix devices |
| 10/06/2009 | CA2291048C Dehydration plant |
| 10/01/2009 | US20090247732 Synthesis of glycopeptides with superior pharmacokinetic properties |
| 10/01/2009 | US20090247580 Nitroxide radioprotector formulations and methods of use |
| 10/01/2009 | US20090246827 Recombinant toxin fragments |
| 10/01/2009 | US20090246148 Medicinal aerosols and methods of delivery thereof |
| 09/30/2009 | EP2105504A2 Genes and proteins, and their use |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543500A Dhea composition and method |
| 09/30/2009 | CN100545160C Diamine derivatives |
| 09/30/2009 | CN100544726C DHEA composition and method |
| 09/29/2009 | US7595430 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders |
| 09/29/2009 | US7595390 Industrially scalable nucleoside synthesis |
| 09/29/2009 | US7595305 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 09/29/2009 | US7595198 Biotinated macromolecules having protein reactive groups that react with functional groups on proteins including sulfhydryl and amine groups, used in the detection and isolation of targets from heterologous mixtures |
| 09/29/2009 | US7595148 Methods and compositions for modulating T lymphocytes |
| 09/29/2009 | US7595064 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 09/29/2009 | US7595060 Induce immunology response; vaccine that includes a dendritic cell loaded with a yeast vehicle and antigen |
| 09/29/2009 | CA2521391C Potassium salt of s-omeprazole as intermediate in the preparation of the magnesium salt of s-omeprazole trihydrate |
| 09/29/2009 | CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors |
| 09/24/2009 | WO2004045516A9 Compositions and methods for the diagnosis and treatment of tumor |
| 09/24/2009 | US20090239897 Novel compounds |
| 09/24/2009 | US20090239892 Pyridomorphinans, pyridazinomorphinans and use thereof |
| 09/24/2009 | US20090239824 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 09/24/2009 | US20090238868 Abuse-resistant oral dosage forms and method of use thereof |
| 09/24/2009 | US20090238864 Dna vaccines encoding heat shock proteins |
| 09/24/2009 | US20090238841 Hiv vaccine formulations |
| 09/24/2009 | US20090238835 Therapeutic use of anti-cs1 antibodies |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | US20090238827 Therapeutic use of anti-cs1 antibodies |
| 09/24/2009 | US20090238821 Humanized antibodies that sequester amyloid beta peptide |
| 09/24/2009 | US20090238758 Random and non-random alkylene oxide polymer alloy compositions |
| 09/23/2009 | EP2103691A1 T helper cell epitopes |
| 09/23/2009 | EP2103303A2 Controlled release formulation |
| 09/23/2009 | CN100543621C Pharmaceutical compounding systems and methods |
| 09/23/2009 | CN100542609C Compositions comprising dietary fat complex and methods for their use |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/23/2009 | CN100542539C Pharmaceutical compositions for acute glucocorticoid therapy |
| 09/22/2009 | US7592361 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 09/22/2009 | US7592350 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 09/22/2009 | US7592338 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 09/22/2009 | US7592306 Reducing immune response against mismatched transplanted organs such as kidney, heart, lung, liver, pancreas, bone marrow and peripheral stem cells |
| 09/22/2009 | US7592171 Vibrio cholerae with improved biological safety features in freeze dried form |
| 09/22/2009 | CA2508139C Escape mutants of newcastle disease virus as marker vaccines |
| 09/22/2009 | CA2194476C Anti-adhesion agent |
| 09/17/2009 | US20090234021 Treatment of Demyelinating Conditions |
| 09/17/2009 | US20090233857 Dna vaccine compositions and methods of use |
| 09/16/2009 | EP2100955A2 Attenuated mutants of human parainfluenza virus type 1 (HPIV1) |
| 09/16/2009 | EP2100619A1 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/16/2009 | EP2100605A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 09/16/2009 | EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 09/16/2009 | EP1192125B9 Mono-substituted 3-propyl gamma-aminobutyric acids |
| 09/16/2009 | EP0941087B1 Topical formulations containing as a therapeutic active agent a monoglyceride for treating of mucosa infections |
| 09/16/2009 | CN101531631A Substituted pyridinones as modulators of p38 map kinase |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540558C High viscosity xanthan polymer preparations |
| 09/16/2009 | CN100539862C Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| 09/15/2009 | US7589238 Treatment of hyperphosphatemia using crosslinked small molecule amine polymers |
| 09/15/2009 | US7589119 Less toxicity; side effects redution; administering substituted p-chlorobenzene and a pyrrolethoxybenzene |
| 09/15/2009 | US7588929 Improved bacteriophage compositions comprising specific sugars that reduce or abolish the bacterial phage-neutralizing activity; used to treat infectious diseases |
| 09/15/2009 | CA2408417C Local anesthetic methods and kits |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/10/2009 | US20090227676 Methods and compositions for treating cancer |
| 09/10/2009 | US20090227658 Methods and compositions for immunization against hiv |
| 09/10/2009 | US20090227504 Pegylated Factor VII Glycoforms |
| 09/10/2009 | US20090226413 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226410 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226400 Continuous delivery methods for treating hepatitis virus infection |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP1660045A4 Topical delivery system containing colloidal crystalline arrays |
| 09/09/2009 | EP1478401B1 Compositions comprising dietary fat complexer and methods for their use |
| 09/09/2009 | EP1165096B1 Use of cytidine derivatives for the treatment of leukaemia |
| 09/09/2009 | CN101525303A Novel 9- substituted minocycline compounds |
| 09/09/2009 | CN101524540A Selective dopamine D4 receptor agonists used for treating sexual disorder |
| 09/09/2009 | CN101524339A Fentanyl patch |
| 09/09/2009 | CN100537764C Metabolic protein for weed-control agent, its gene, and its use |
| 09/09/2009 | CN100536922C Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/08/2009 | US7585967 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 09/08/2009 | US7585870 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
| 09/08/2009 | US7585843 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 09/08/2009 | US7585837 derivatization of the drug with 9-fluorenylmethoxycarbonyl (Fmoc) or 2-sulfo-9-fluorenylmethoxycarbonyl (FMS) removable under mild basic conditions by attaching a protein or polymer carrier to derivatized drug molecule,such carrier serving for delivery of the drug |